Syngene -Clinical Development

syngeneintl.com

Syngene is a leading Asian CRO that provides a broad range of discovery, development, manufacturing and clinical development solutions to biopharma companies. Syngene's clinical development services span a broad spectrum of activities including human pharmacology, bioanalytical research, central laboratory, clinical operations, medical writing, medical monitoring, safety management, pharmacovigilance, clinical data management & biostatistics and regulatory services supporting early-phase through late-phase clinical development programs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

IAMBIC THERAPEUTICS ANNOUNCES CLOSE OF OVERSUBSCRIBED $100 MILLION SERIES B FINANCING TO ADVANCE AI-DISCOVERED THERAPEUTICS INTO CLINICAL DEVELOPMENT

Business Wire | October 10, 2023

news image

Iambic Therapeutics a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, today announced the closing of an oversubscribed $100 million Series B financing co-led by Ascenta Capital and Abingworth, and also including new investors NVIDIA, Illumina Ventures, Gradiant Corporation, and independent board member Bill Rastetter. Existing inve...

Read More

Business Insights, PHARMACY MARKET

SHIELDS HEALTH SOLUTIONS INCREASES SPECIALTY PHARMACY SERVICES NATIONWIDE

Shields Health Solutions | January 12, 2023

news image

Shields Health Solutions (ShieldsRx), one of the leading specialty pharmacy accelerators, informed that the company has now collaborated with more than 850 hospitals at over 75 health systems after adding four more health systems. ShieldsRx health system partners are well-positioned to improve therapy management and care coordination for critical patients, improving outcomes through high-quality care. Its health systems serve 1 million patients in 44 states. Matt Conw...

Read More

Pharmacy Market

ORBIT DISCOVERY AND WUXI APPTEC SIGN AGREEMENT TO ACCESS PEPTIDE DISCOVERY AND OPTIMISATION TECHNOLOGIES

Orbit Discovery | March 08, 2022

news image

Orbit Discovery a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry. Orbit will combine its leading peptide discovery platform and experience with WuXi AppTec’s downstream capabilities. Specifically, Orbit gains access to WuXi AppTec’s expertise in peptide optimisation, peptide p...

Read More

Business Insights, PHARMACY MARKET

INSITRO APPOINTS PHILIP TAGARI, INDUSTRY-LEADING SCIENTIST AND DRUG HUNTER, AS CHIEF SCIENTIFIC OFFICER

insitro | December 02, 2022

news image

insitro, a machine learning-powered drug discovery and development company announced that Philip Tagari has been appointed as chief scientific officer. Tagari joins insitro following a 24-year career at Amgen, where he has led the organization's research platforms for over a decade as vice president, research - therapeutic discovery. “I am deeply excited to partner with Philip on insitro’s journey to build a transformative biology platform for...

Read More
news image

PHARMACY MARKET

IAMBIC THERAPEUTICS ANNOUNCES CLOSE OF OVERSUBSCRIBED $100 MILLION SERIES B FINANCING TO ADVANCE AI-DISCOVERED THERAPEUTICS INTO CLINICAL DEVELOPMENT

Business Wire | October 10, 2023

Iambic Therapeutics a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, today announced the closing of an oversubscribed $100 million Series B financing co-led by Ascenta Capital and Abingworth, and also including new investors NVIDIA, Illumina Ventures, Gradiant Corporation, and independent board member Bill Rastetter. Existing inve...

Read More
news image

Business Insights, PHARMACY MARKET

SHIELDS HEALTH SOLUTIONS INCREASES SPECIALTY PHARMACY SERVICES NATIONWIDE

Shields Health Solutions | January 12, 2023

Shields Health Solutions (ShieldsRx), one of the leading specialty pharmacy accelerators, informed that the company has now collaborated with more than 850 hospitals at over 75 health systems after adding four more health systems. ShieldsRx health system partners are well-positioned to improve therapy management and care coordination for critical patients, improving outcomes through high-quality care. Its health systems serve 1 million patients in 44 states. Matt Conw...

Read More
news image

Pharmacy Market

ORBIT DISCOVERY AND WUXI APPTEC SIGN AGREEMENT TO ACCESS PEPTIDE DISCOVERY AND OPTIMISATION TECHNOLOGIES

Orbit Discovery | March 08, 2022

Orbit Discovery a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry. Orbit will combine its leading peptide discovery platform and experience with WuXi AppTec’s downstream capabilities. Specifically, Orbit gains access to WuXi AppTec’s expertise in peptide optimisation, peptide p...

Read More
news image

Business Insights, PHARMACY MARKET

INSITRO APPOINTS PHILIP TAGARI, INDUSTRY-LEADING SCIENTIST AND DRUG HUNTER, AS CHIEF SCIENTIFIC OFFICER

insitro | December 02, 2022

insitro, a machine learning-powered drug discovery and development company announced that Philip Tagari has been appointed as chief scientific officer. Tagari joins insitro following a 24-year career at Amgen, where he has led the organization's research platforms for over a decade as vice president, research - therapeutic discovery. “I am deeply excited to partner with Philip on insitro’s journey to build a transformative biology platform for...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us